PerkinElmer: Michelle McMurry-Heath
Michelle McMurry-Heath has joined the board of directors of PerkinElmer. She is the president and CEO of the Biotechnology Innovation Organization (BIO). Her previous roles include VP of global external innovation and global leader for regulatory sciences at Johnson & Johnson and associate director for science at the US Food and Drug Administration Center for Devices and Radiological Health. McMurry-Heath has an MD/PhD from Duke University School of Medicine and a BA in biochemistry and molecular biology from Harvard University.